Amphastar Pharmaceuticals Inc (AMPH)

May 04, 2025

Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday - MarketBeat

May 04, 2025

May 03, 2025

Insider Sell: Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH) - GuruFocus

May 03, 2025

May 03, 2025

Raymond James Financial Inc. Acquires Shares of 92,904 Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

May 03, 2025

May 02, 2025

Is the Options Market Predicting a Spike in Amphastar (AMPH) Stock? - MSN

May 02, 2025

May 02, 2025

Take off with Amphastar Pharmaceuticals Inc (AMPH): Get ready for trading - Sete News

May 02, 2025

May 02, 2025

Adversity is less terrifying than hope: Inovio Pharmaceuticals Inc (INO) - Sete News

May 02, 2025

May 01, 2025

Envestnet Asset Management Inc. Sells 2,463 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

May 01, 2025

Apr 30, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 30, 2025

Apr 30, 2025

Amphastar Pharmaceuticals Q1 2025 Earnings: Key Financial Updates Coming May 7What to Watch - Stock Titan

Apr 30, 2025

Apr 30, 2025

Barclays PLC Buys 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 30, 2025

Apr 30, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by Oberweis Asset Management Inc. - MarketBeat

Apr 30, 2025

Apr 29, 2025

Learn to Evaluate (AMPH) using the Charts - news.stocktradersdaily.com

Apr 29, 2025

Apr 29, 2025

Fuller & Thaler Asset Management Inc. Sells 127,841 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 29, 2025

Apr 28, 2025

Anaphylaxis Treatment Market Size in 7MM is expected to grow at - openPR.com

Apr 28, 2025

Apr 28, 2025

Generic Pharmaceuticals Stocks Q4 Teardown: Viatris (NASDAQ:VTRS) Vs The Rest - Yahoo Finance

Apr 28, 2025

Apr 26, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stock Position Boosted by Marshall Wace LLP - MarketBeat

Apr 26, 2025

Apr 25, 2025

Epoch Investment Partners Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 25, 2025

Apr 25, 2025

Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes - ACCESS Newswire

Apr 25, 2025

Apr 25, 2025

Mesirow Institutional Investment Management Inc. Has $14.12 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 25, 2025

Apr 24, 2025

JPMorgan Chase & Co. Has $5.70 Million Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 24, 2025

Apr 23, 2025

Legal & General Group Plc Sells 3,871 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 23, 2025

Apr 23, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Acquired by LPL Financial LLC - Defense World

Apr 23, 2025

Apr 21, 2025

BofA Adjusts Price Target on Amphastar Pharmaceuticals to $31 From $36 - marketscreener.com

Apr 21, 2025

Apr 21, 2025

U.S. Naloxone Market Is Booming So Rapidly 2025-2032 -Amphastar Pharmaceuticals Inc., Emergent BioSolutions Inc - openPR.com

Apr 21, 2025

Apr 21, 2025

BofA Adjusts Price Target for Amphastar (AMPH) Amid Q1 Uncertain - GuruFocus

Apr 21, 2025

Apr 20, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - MarketBeat

Apr 20, 2025

Apr 20, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Stake Lessened by Portolan Capital Management LLC - MarketBeat

Apr 20, 2025

Apr 19, 2025

JPMorgan Chase & Co. Sells 385,349 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 19, 2025

Apr 18, 2025

Renaissance Technologies LLC Acquires 36,100 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat

Apr 18, 2025

Apr 18, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Alliancebernstein L.P. - Defense World

Apr 18, 2025

Apr 17, 2025

Geode Capital Management LLC Lowers Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 17, 2025

Apr 16, 2025

Amphastar stock hits 52-week low at $22.73 amid market challenges By Investing.com - Investing.com South Africa

Apr 16, 2025

Apr 16, 2025

Amphastar stock hits 52-week low at $22.73 amid market challenges - Investing.com Canada

Apr 16, 2025

Apr 16, 2025

Bessemer Group Inc. Buys 11,609 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Franklin Resources Inc. Sells 1,060 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Apr 16, 2025

Apr 15, 2025

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Pharma Stock to Buy for Long Term Growth? - Insider Monkey

Apr 15, 2025

Apr 15, 2025

2 Reasons to Like AMPH and 1 to Stay Skeptical - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

Amphastar Pharmaceuticals' (AMPH) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Apr 15, 2025

Apr 15, 2025

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Wellington Management Group LLP - Defense World

Apr 15, 2025

Apr 15, 2025

Hyaluronidase Market Growth, Trends & Insights 2024-2031 | Top - openPR.com

Apr 15, 2025

Apr 14, 2025

Federated Hermes Inc. Lowers Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Apr 14, 2025